Skip to main content
SpringerLink
Log in

Hämostaseologische Erkrankungen

  • Chapter
Medizinische Therapie 2005|2006

  • 33 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Andrew M, David M, Adams M et al. (1994) Venous thromboenbolic compli-cations (VTE) in children: first analyses of the Canadian registry of VTE. Blood 83: 1251–1257

    CAS  PubMed  Google Scholar 

  • Andrew M, Michelson AD, Bovill E, Leaker M, Massicotte MP (1998) Guide-lines for antithromboc therapy in pediatric patients. J Pediatr 132: 576–588

    Google Scholar 

  • Bertina RM, Koelerman BP, Koster T et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64–67

    Article  CAS  PubMed  Google Scholar 

  • Blanchette V, Imbach P, Andrew M et al. (1994) Randomized trial of intravenous immunoglobin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344: 703–707

    Article  CAS  PubMed  Google Scholar 

  • Ehrenforth S, Kreuz W, Funk M et al. (1994) Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors. Thromb Haemost 72: 782–786

    CAS  Google Scholar 

  • George JN (2000) Initial management of immune thrombocytopenic purpura in children: Is supportive counseling without therapeutic intervention sufficient? J Pediatr 137: 698–699

    Google Scholar 

  • George JN, Woolf SH, Raskob GE et al. (1996) Review: ITP. A practice guideline developed by explicit methods for the American Society of Hematology. Blood 78: 3–40

    Google Scholar 

  • Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U (1999) Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscl Thromb Vasc Biol 19: 2568–2572

    CAS  PubMed  Google Scholar 

  • Kreuz W, Ehrenforth S, Funk M (1995) Immune tolerance therapy in pae-diatric haemophiliacs with factor VIII inhibitors: 14 years follow-up. Haemophilia 1: 24–32

    Google Scholar 

  • Lilleyman JS (1999) Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol 105: 871–875

    Article  CAS  PubMed  Google Scholar 

  • Mannucci PM (2001) Treatment of von Willebrand disease. Thromb Haemost 86: 149–153

    CAS  PubMed  Google Scholar 

  • Massicotte MP, Adams M, Marzinotto V, Brooker LA, Andrew M (1999) Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study. J Pediatr 128: 313–318

    Google Scholar 

  • Medeiros D, Buchanan GR (2000) Idiopathic thrombocytopenic purpura: beyond consensus. Curr Opin Pediatr 12: 4–9

    Article  CAS  PubMed  Google Scholar 

  • Nowak-Göttl U, Kosch A, Schlegel N (2001) Thromboembolism in newborns, infants and children. Thromb Haemost 86: 464–474

    PubMed  Google Scholar 

  • Nowak-Göttl U, Sträter R, Heinecke A, Junker R, Koch HG, Schuierer G, Eckardstein A (1999) Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke. Blood 94: 3678–3682

    PubMed  Google Scholar 

  • Ruggeri ZM (1999) Structure and function of von Willebrand factor. Thromb Haemost 82: 576–584

    CAS  PubMed  Google Scholar 

  • Schimpf K (1994) Therapie der Hämophilien. Hämostaseologie 14: 44–54

    Google Scholar 

  • Schneppenheim R, Thomas KB, Sutor AH (1995) Von Willebrand disease in childhood. Semin Thromb Hemost 21: 261–275

    CAS  PubMed  Google Scholar 

  • Schramm W (1994) Konsensus-Empfehlungen zur Hämophiliebehandlung in Deutschland. Hämostaseologie 14: 81–83

    Google Scholar 

  • Sutor AH, Gaedicke G (1998) Acute autoimmune thrombocytopenia (Review) (40 refs). Baillieres Clin Haematol 11: 381–389

    CAS  PubMed  Google Scholar 

  • Sutor AH, Harms A, Kaufmehl K (2001) Acute immune thrombocytopenia (ITP) in childhood. Retrospective and prospective survey in Germany. Sem Thromb Hemostas (in press)

    Google Scholar 

  • Univar A, Warrier I, Lusher JM (2000) Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors. Haemophilia 6: 150–157

    Google Scholar 

  • White GC (2001) Gene therapy in hemophilia: Clinicals trials update. Thromb Haemost 86: 172–177

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. Rosemarie Schobess
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg, D-93042, Regensburg

    Jürgen Schölmerich

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Schobess, R. (2005). Hämostaseologische Erkrankungen. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_201

Download citation

  • DOI: https://doi.org/10.1007/3-540-27385-9_201

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21226-3

  • Online ISBN: 978-3-540-27385-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation